Legend Biotech (LEGN) Tax Provisions (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Tax Provisions data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Tax Provisions fell 33.33% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 91.3% YoY) and the FY2024 annual result came in at $18.9 million, up 1094.74% from the prior year.
• Tax Provisions grew to $1.2 million in Q1 2026, from -$616000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $23.6 million in Q4 2024 to a low of -$4.4 million in Q3 2024.
• A 5-year average of $1.2 million and a median of -$142500.0 in 2022 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2022 — Tax Provisions tumbled 4093.14% — and 2025, when it soared 36100.0%.
• Tracing LEGN's Tax Provisions over 5 years: stood at $125000.0 in 2022, then sank by 1516.0% to -$1.8 million in 2023, then surged by 1431.41% to $23.6 million in 2024, then slumped by 102.61% to -$616000.0 in 2025, then surged by 294.81% to $1.2 million in 2026.
• The last three Tax Provisions figures came in at $1.2 million (Q1 2026), -$616000.0 (Q3 2025), and -$582000.0 (Q2 2025), per Business Quant data.